The FORCE consortium is pleased to announce the launch of its first Joint Call for Proposals 2027, supporting international pragmatic clinical trials for patients with rare and/or hard-to-treat cancers.

The call is open under the theme “Quality of life–integrated approaches to improve treatment of rare and/or hard-to-treat cancers through pragmatic clinical trials” and offers a total budget of  approximately 13 million EUR.

Key deadlines

Pre-proposals must be submitted by 21 September 2026, 2pm CET via the Fondation ARC electronic submission system. The submission system opens on 7 July 2026.

Successful applicants at the pre-proposal stage will be invited to submit full proposals in early 2027, with final results expected by May 2027.

How to apply

Full details, including eligibility criteria, budget guidelines and application requirements, are available HERE